Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Tarriff Scott Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 9,511 shares @ $15.23, valued at $144.9k
Sold 10,024 shares @ $14.41, valued at $144.4k
Sold 710 shares @ $15.11, valued at $10.7k
05/18/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $19.98, valued at $299.7k
05/15/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $20.71, valued at $310.7k
Sold 3,131 shares @ $19.69, valued at $61.6k
Sold 11,869 shares @ $20.42, valued at $242.4k
Sold 14,800 shares @ $21.06, valued at $311.7k
Sold 200 shares @ $21.52, valued at $4.3k
03/02/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 3,113 shares @ $28, valued at $87.2k
Granted 70,900 shares @ $0
01/24/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 3,732 shares @ $33.64, valued at $125.5k
01/09/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 3,827 shares @ $29.26, valued at $112k
03/02/2022 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 34,800 shares @ $0
04/05/2021 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Gifted 16,340 shares @ $0
Paid exercise price by delivering 16,278 shares @ $41.87, valued at $681.6k
Exercised 31,201 options to buy @ $8.78, valued at $273.9k
01/26/2021 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 4,631 shares @ $47.7, valued at $220.9k
11/12/2020 4 Tarriff Scott (Former Director) has filed a Form 4 on Synthetic Biologics, Inc.
01/27/2020 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 7,548 shares @ $57.98, valued at $437.6k
01/07/2020 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 58,300 shares @ $0
Granted 145,700 options to buy @ $59.795, valued at $8.7M
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2019 4 Tarriff Scott (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns: Granted 250,000 options @ $0.418, valued at $104.5k
04/03/2019 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 24,975 shares @ $50.15, valued at $1.3M
03/04/2019 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 12,000 shares @ $50.51, valued at $606.1k
Sold 12,428 shares @ $51.81, valued at $643.9k
02/04/2019 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 29,185 shares @ $41.52, valued at $1.2M
Sold 900 shares @ $42.3, valued at $38.1k
01/25/2019 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 61,300 shares @ $0
Granted 137,200 options to buy @ $42.4, valued at $5.8M
01/04/2019 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 6,500 shares @ $39.3, valued at $255.5k
Sold 8,500 shares @ $40.03, valued at $340.3k
Sold 10,597 shares @ $39.04, valued at $413.7k
Sold 5,670 shares @ $39.7, valued at $225.1k
Sold 302 shares @ $40.57, valued at $12.3k
01/02/2019 4 Tarriff Scott (Director) has filed a Form 4 on ZIOPHARM ONCOLOGY INC
Txns: Granted 126,700 options to buy @ $1.87, valued at $236.9k
12/07/2018 4 Tarriff Scott (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns: Granted 79,500 options @ $0.6895, valued at $54.8k
07/03/2018 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Exercised 124,804 options to buy @ $4.04, valued at $504.2k
04/03/2018 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 57,895 shares @ $52.69, valued at $3.1M
Exercised 113,104 options to buy @ $4.04, valued at $456.9k
01/09/2018 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 157,000 options to buy @ $59.14, valued at $9.3M
Granted 189,000 options to buy @ $0
01/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2017 4 Tarriff Scott (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns: Granted 200,000 options @ $0.52, valued at $104k
01/06/2017 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
01/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/02/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/18/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
04/05/2016 4 Tarriff Scott (President and CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 30,765 shares @ $40.63, valued at $1.2M
03/03/2016 4 Tarriff Scott (President and CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 7,802 shares @ $62.7, valued at $489.2k
Sold 11,978 shares @ $63.52, valued at $760.8k
02/02/2016 4 Tarriff Scott (President and CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 5,367 shares @ $66.03, valued at $354.4k
Sold 3,600 shares @ $67.46, valued at $242.9k
Sold 5,260 shares @ $68.52, valued at $360.4k
Sold 2,431 shares @ $69.95, valued at $170k
Sold 1,702 shares @ $71.84, valued at $122.3k
01/05/2016 4 Tarriff Scott (President and CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 11,776 shares @ $85.65, valued at $1M
Sold 2,773 shares @ $87.02, valued at $241.3k
Granted 180,000 options to buy @ $86.15, valued at $15.5M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy